Abstract | BACKGROUND: The potential effects of resistance training on sarcopenia in patients with intestinal failure (IF) are not fully elucidated. This study aimed to explore the efficacy of a resistance training program on appendicular skeletal muscle index (ASMI), physical performance, body composition, biochemical parameters, and health-related quality of life (HRQOL) in patients with IF exhibiting sarcopenia. METHODS: A single-center randomized controlled trial was conducted in a Chinese tertiary teaching hospital. Patients with IF exhibiting sarcopenia were randomly assigned to the exercise group or control group. Participants in the exercise group incorporated four sets of resistance training involving the limbs and abdominal and lower back muscles, six times weekly for 4 weeks. The control group received no specific intervention. The primary outcome was the between-group difference in ASMI 4 weeks after intervention. Secondary outcomes included handgrip strength, 6-m gait speed, body composition, biochemical parameters, and HRQOL. RESULTS: A total of 60 participants (control group 30, age 51.2 ± 12.9 years, women 43.3%; exercise group 30, age 53.9 ± 14.5 years, women 56.7%) completed the 4-week intervention trial. For the primary outcome, significant intervention effects were found in ASMI between the exercise group and the control group (mean difference 0.72, 95% CI, 0.56-0.89, P < 0.001). There were notable differences in handgrip strength (mean difference 2.7, 95% CI, 1.7-3.6, P < 0.001), 6-m gait speed (mean difference 0.08, 95% CI, 0.01-0.35, P = 0.034), body composition (including total cell mass, bone mineral content, skeletal muscle mass, lean mass, visceral fat area, total body water, intracellular water, extracellular water, and segmental water-legs), and biochemical parameters (including IGF-1, prealbumin, and hemoglobin) between the two groups (P < 0.05). No significant intervention benefits were observed for other secondary outcomes, including biochemical parameters (including albumin, total bilirubin, etc.) and HRQOL (P > 0.05). CONCLUSIONS: CLINICAL TRIAL REGISTRATION: www.chictr.org.cn, identifier: ChiCTR2100051727.
|
Authors | Yaqin Xiao, Deshuai Song, Niannian Fu, Li Zhang, Yupeng Zhang, Ruting Shen, Siwen Wang, Gulisudumu Maitiabula, Da Zhou, Sitong Liu, Haoyang Wang, Xuejin Gao, Xinying Wang |
Journal | Clinical nutrition (Edinburgh, Scotland)
(Clin Nutr)
Vol. 42
Issue 10
Pg. 1901-1909
(10 2023)
ISSN: 1532-1983 [Electronic] England |
PMID | 37625319
(Publication Type: Randomized Controlled Trial, Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2023. Published by Elsevier Ltd. |
Chemical References |
- Insulin-Like Growth Factor I
- Prealbumin
|
Topics |
- Humans
- Female
- Adult
- Middle Aged
- Aged
- Sarcopenia
(therapy)
- Muscle Strength
(physiology)
- Insulin-Like Growth Factor I
- Prealbumin
- Hand Strength
- Resistance Training
(methods)
- Quality of Life
- Intestinal Failure
- Muscle, Skeletal
(physiology)
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|